Axsome Therapeutics PEG Ratio

Axsome Therapeutics (AXSM) currently reports a PEG ratio of 63.66. That is above the Healthcare sector average of -5.81. Use the charts on this page to explore Axsome Therapeutics's PEG ratio history and peer comparisons.

Axsome Therapeutics's PEG ratio of 63.66 is higher than the Healthcare sector average of -5.81. That is roughly 1195.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Axsome Therapeutics's market price to a fundamental measure such as earnings, sales, or book value. At 63.66, AXSM can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 63.66, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -5.81. From there, open related valuation or income-statement pages for Axsome Therapeutics, and consider following AXSM for alerts when major investors trade the stock.

Axsome Therapeutics is classified in the Healthcare sector. On PEG ratio, it currently shows 63.66 versus a sector average near -5.81. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AXSM with unrelated industries.